ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,010.54
      -0.01%
      US Tech 100
      16,858.40
      -0.46%
      Dow Jones
      37,978.82
      0.54%
      Brent Oil
      86.66
      0.28%
      Bitcoin
      64,849.24
      2.11%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE
      6. Noventa (NVTA)

      7. Noventa (NVTA) News

      NVTA

      Noventa (NVTA)

      		Date:
      Sort by:
       Showing the most relevant articles for your search:NYSE:NVTA
      DateTimeSourceHeadlineSymbolCompany
      03/06/20248:31AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:NVTAInvitae Corporation
      02/06/20245:07PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:NVTAInvitae Corporation
      01/30/20247:00AMPR Newswire (US)Invitae Partners with BridgeBio Pharma to Harness Genetic Insights for the Discovery of Rare Disease TherapeuticsNYSE:NVTAInvitae Corporation
      01/29/20244:01PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:NVTAInvitae Corporation
      01/24/20244:34PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NYSE:NVTAInvitae Corporation
      01/22/20247:05AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:NVTAInvitae Corporation
      01/22/20247:00AMPR Newswire (US)Invitae Completes Sale of Reproductive Health Assets to NateraNYSE:NVTAInvitae Corporation
      01/18/20244:10PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:NVTAInvitae Corporation
      12/21/20239:20PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVTAInvitae Corporation
      12/21/20239:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVTAInvitae Corporation
      12/14/20234:29PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:NVTAInvitae Corporation
      12/13/20234:07PMPR Newswire (US)Invitae Divests Ciitizen Health Data Platform and Implements Further Cost CutsNYSE:NVTAInvitae Corporation
      12/11/20234:41PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:NVTAInvitae Corporation
      11/17/20234:48PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:NVTAInvitae Corporation
      11/15/20234:22PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:NVTAInvitae Corporation
      11/14/20237:58PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVTAInvitae Corporation
      11/14/20237:55PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:NVTAInvitae Corporation
      11/08/20234:36PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:NVTAInvitae Corporation
      11/08/20234:05PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:NVTAInvitae Corporation
      11/08/20234:01PMPR Newswire (US)Invitae Reports Third Quarter 2023 Financial ResultsNYSE:NVTAInvitae Corporation
      11/06/20234:00PMPR Newswire (US)Invitae Launches Enhanced Chemistry of MRD Test to Better Serve Biopharmaceutical Clinical and Research PartnershipsNYSE:NVTAInvitae Corporation
      11/01/20236:59AMPR Newswire (US)Invitae to Announce Third Quarter 2023 Financial Results on Wednesday, November 8, 2023NYSE:NVTAInvitae Corporation
      10/25/202311:00AMPR Newswire (US)Landmark Study Reveals Magnitude of Uncertain Results in Clinical Genetic Testing for Hereditary Disease, Points to Evidence-Based Solutions to Reach Definitive ResultsNYSE:NVTAInvitae Corporation
      10/20/20236:04PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVTAInvitae Corporation
      10/19/20234:38PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:NVTAInvitae Corporation
      10/19/20234:30PMPR Newswire (US)Invitae Appoints Dr. David Sholehvar as Chief Operating OfficerNYSE:NVTAInvitae Corporation
      10/12/20234:15PMPR Newswire (US)Rural Hospital System Demonstrates the Clinical Benefits of Implementing Universal Hereditary Cancer Testing in Patients with Breast CancerNYSE:NVTAInvitae Corporation
      10/10/20234:30PMPR Newswire (US)Invitae to Present Data at the National Society of Genetic Counselors 42nd Annual Conference That Supports Advancements in Medical GenomicsNYSE:NVTAInvitae Corporation
      10/03/202312:07PMPR Newswire (US)Invitae's Common Hereditary Cancers Panel Receives FDA Market AuthorizationNYSE:NVTAInvitae Corporation
      10/02/20239:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVTAInvitae Corporation
       Showing the most relevant articles for your search:NYSE:NVTA